CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0658
(Tag F0658)
Could have caused harm · This affected 1 resident
Based on observation, interview, record review, review of facility Policy, and review of the Kentucky Board of Nursing (KBN) Advisory Opinion Statement (AOS) #14, it was determined the facility failed...
Read full inspector narrative →
Based on observation, interview, record review, review of facility Policy, and review of the Kentucky Board of Nursing (KBN) Advisory Opinion Statement (AOS) #14, it was determined the facility failed to meet professional standards of quality.
Observation on 09/26/18 of the 200 Hallway medication cart, revealed an unidentified pill, which was loose in a cup, and not in the packaging.
The findings include:
Review of the facility Medication Ordering and Receiving from Pharmacy Policy, undated, revealed Medications are labeled in accordance with facility requirements, state, and federal laws. Each Prescription medication label includes resident's name; specific directions for use, including route of administration; medication name; strength of the medication; Prescriber's name; date dispensed; quantity of medication; expiration date of medication; prescription number; accessory labels; and initials of dispensing pharmacist.
Review of the KBN, AOS #14, revised October 2015, Roles of Nurses in the implementation of Patient Care Orders, revealed in accordance with Kentucky Revised Statutes (KRS) 314.021 (2), nurses are responsible and accountable for making decisions that are based upon the individual's educational preparation and current clinical competence in nursing and requires licensees to practice nursing with reasonable skill and safety. Further review revealed licensed nurses should administer medication and treatment as prescribed by the Physician, Physician Assistant, Dentist, or Advanced Practice Registered Nurse (ARNP).
Observation on 09/26/18 at 9:30 AM, of the medication cart on the 200 Hallway with Certified Medication Aide (CMA) #1, revealed there was a single loose blue pill in a medication cup without packaging or identifying information.
Interview with CMA #1, on 09/26/18 at 4:00 PM, revealed she did not leave the loose blue pill in the medication cart. CMA #1 stated medications left loose and not in the packaging in the medication cart would need to be disposed of and reported to the Director of Nursing (DON).
Interview with CMA #3, on 09/26/18 at 4:24 PM, revealed if a resident refused or did not take a medication once the package was opened, the medication should be properly discarded and the reason the medication was not administered should be documented on the Medication Administration Record (MAR). Further interview revealed a loose pill left in the medication cart with no identifying packaging, should not be administered to a resident and the medication would need to be taken to the DON for further investigation.
Interview with Registered Nurse (RN) #1, on 09/27/18 at 10:30 AM, revealed she left the loose blue pill in the cup in the the medication cart. Per interview, the medication was Proscar (medication used to treat Prostatic Hyperplasia) and the medication belonged to Resident #93. RN #1 stated Resident #93 did not want to take the medication (Proscar) at the time scheduled time, and she left the loose Proscar pill in a cup for administration later when the resident was ready for the medication. Continued interview revealed RN #1 was aware this was not proper procedure. RN #1 further stated, as a standard of practice she would not administer a medication from the medication cart that was not labeled or in the package.
Interview with the DON, on 09/26/18 at 10:00 AM, revealed through her investigation she discovered the unidentified blue pill left in the medication cart on the 200 Hallway belonged to Resident #93. The DON stated the pill was identified by the facility as Proscar 5 milligrams (mg) which the resident was to receive each morning.
Additional interview on 09/27/18 at 5:10 PM, with the DON, revealed it was her expectation the nurses and CMAs dispose of medication in the proper manner, if the resident refused the medication. Per interview, the nurses and CMAs were also to follow the facility policies, guidelines and practices for reporting a missed dose. The DON stated she would not expect staff to administer a medication which was left in the cart opened without a package or pharmacy label as this created the potential for a medication error.
Interview with the Administrator, on 09/27/18 at 5:43 PM, revealed nursing staff should not leave a loose pill which was not in the package in the medication cart for later administration as this was not safe. Per interview, the nurses and CMAs were to follow Physician's Orders, facility policies, and the pharmacy and drug manufacturer's guidelines and recommendations when administering medications.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0659
(Tag F0659)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, record review, review of the National Pressure Ulcer Advisory Panel (NPUAP) guidelines, review ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, record review, review of the National Pressure Ulcer Advisory Panel (NPUAP) guidelines, review of the Manufacturer's Recommendations for Air Mattresses, and review of the Centers for Medicare and Medicaid Services, Resident Assessment Instrument (RAI) Manual 3.0, it was determined the facility failed to ensure services provided are delivered by qualified individuals who have the skills, experience and knowledge to provide care and services that meet the resident's needs for one (1) of five (5) sampled residents (Resident #15).
Resident #15's Comprehensive Care Plan (CCP) revealed the resident had the potential for impaired skin integrity, initiated 01/07/15, and revised 09/26/18, which included an intervention for a weekly skin assessment by a licensed nurse. Observation of a skin assessment for Resident #15 on 09/27/18, revealed the resident had an identified reddened area over a bony prominence of the coccyx, and review of the current September 2018 Physician's Orders, revealed a treatment order initiated 03/01/18, for a foam dressing treatment for the area. However, review of the weekly skin assessments, dated 06/15/18 through 09/21/18, revealed the reddened area to the resident's coccyx was only assessed two (2) times during this review period.
In addition, Resident #15's CCP revealed an intervention to assist with turning and repositioning every two (2) hours and as needed; however, observation on 09/25/18, 09/26/18, and 09/27/18, revealed the resident was lying on his/her back, and had not been turned and repositioned every two (2) hours.
Furthermore, Resident #15's CCP revealed an intervention for a pressure redistributing mattress, Low Air Loss (LAL). However, staff were not regulating or knowledgeable of the resident's appropriate Low Air Loss (LAL) mattress setting in order to ensure this was an effective treatment to prevent or to heal skin breakdown.
The findings include:
Interview with the Director of Nursing (DON), on 09/27/18 at 6:01 PM, revealed the facility did not have a policy related to following the Care Plan; however, used the Centers for Medicare and Medicaid Services, Resident Assessment Instrument (RAI) Manual 3.0 as a guide. Further interview revealed the facility did not have a policy specific to skin assessments or prevention of pressure ulcers, but used NPUAP guidelines. Continued interview revealed the facility did not have a policy related to Air Mattresses; however, followed the Manufacturer's Recommendations.
Review of the Centers for Medicare and Medicaid Services, Resident Assessment Instrument (RAI) Manual 3.0, dated October 2016, revealed the Comprehensive Care Plan is an interdisciplinary communication tool and must include measurable objectives and time frames and must describe the services to be furnished to attain or maintain the resident's highest practicable physical, mental, and psychosocial well-being. Further review revealed the services provided or arranged must be consistent with each resident's written Plan of Care.
Review of the Pressure Injury Prevention Points, dated April, 2016, from the National Pressure Ulcer Advisory Panel (NPUAP) organization, revealed all individuals at risk for pressure injury should be provided inspection of the skin at least daily for signs of pressure injury, especially nonblanchable erythema. Additional review revealed these individuals should be provided assistance with turning and repositioning based on a frequency for turning according to the support surface in use. Continued review revealed the level of immobility, exposure to moisture, body size and weight of the individual should be considered when choosing a support surface. Further, an individual should continue to be repositioned when placed on any support surface.
Review of the Operation Manual for the LAL Air Mattress utilized by the facility, revealed the intended use of the mattress series is to provide individualized comfort and to reduce the incidence of pressure ulcers. Additionally, the Weight Setting Selection should be adjusted by choosing the patient's corresponding weight setting using the plus and minus buttons. Continued review revealed recommendations to follow the Hand Check procedure to decide the appropriate pressure level. Further, the Hand Check procedure is used to see if a suitable pressure is selected by sliding one hand between the air mattress and the foam base or bed frame to feel the patient's buttocks. An acceptable range is approximately one (1) inch to one and a half (1.5) inches.
Review of Resident #15's Electronic Medical Record (EMR) revealed the facility admitted the Resident on 03/02/16, with diagnoses including Alzheimer's Disease, Depressive Disorder, Anxiety Disorder, Heart Failure, Chronic Kidney Disease Stage three (III), Anorexia, Adult Failure to Thrive, Neoplasm of uncertain behavior of Bladder, History of Transient Ischemic Attack and Cerebral Infarction, and Localized Edema.
Review of Resident #15's Quarterly Minimum Data Set (MDS) Assessment, dated 07/09/18, revealed the facility assessed the resident as having severe cognitive impairment. Further review of the MDS Assessment revealed the facility assessed the resident as requiring extensive assistance of two (2) staff for bed mobility and toileting; and as frequently incontinent of bowel and bladder. Further, per the MDS Assessment, the Resident weighed one hundred and twenty nine (129) pounds and was at risk of developing pressure ulcers.
Review of Resident #15's Order Summary Report, dated 01/01/18 through 09/30/18, revealed Active Physician's Order with an original date of 03/01/18, to turn and reposition the resident every two (2) hours and as needed (PRN); and specialty mattress LAL every shift. Further review revealed Active Physician's Orders with an original date of 03/01/18, to pad and protect coccyx with foam dressing due to blanchable redness, and change every three (3) days and as needed (PRN).
Review of the Treatment Administration Record (TAR), dated June 2018 through September 2018, revealed Resident #15's coccyx treatment with foam dressing, was signed as administered daily per Physician's Orders.
Review of Resident #15's Weekly Skin Assessments, dated 06/15/18 through 09/21/18, revealed skin assessments were performed weekly; however, there was no documented evidence staff monitored the reddened area to the coccyx weekly, as per the CCP. The Skin assessment dated [DATE], revealed the coccyx area was described as red/blanchable with foam dressing, clean dry and intact. The Skin assessment dated [DATE], revealed the coccyx area was described as a pink blanchable area with treatment in place. However, these were the only Skin Assessments from 06/15/18 through 09/21/18, which documented the presence of discoloration to Resident #15's coccyx.
Review of the Braden Scale for Predicting Pressure Sore Risk Assessment, dated 09/26/18, revealed Resident #15 was at mild risk for developing a pressure sore. The risk factors included: could not always communicate discomfort or the need to be turned; very limited mobility as evidence by being unable to make frequent or significant changes independently; occasionally moist; and potential for friction and shearing of the skin when moved.
Review of the Comprehensive Care Plan (CCP), initiated 01/07/15, revised 09/26/18, revealed Resident #15 had the potential for impaired skin integrity related to debility and often staying in bed; refusing turning and re-positioning at times; history of Suspected Tissue Damage Injury to left heel; and red coccyx. The goal stated the resident was to have intact skin and the risk for impaired skin integrity was to be minimized through nursing interventions/education. Interventions included, but were not limited to: weekly skin assessments by licensed staff to monitor for any indication of skin breakdown initiated 01/07/15; turn and reposition every two (2) hours and PRN initiated 02/21/18; and pressure redistributing mattress (LAL mattress) initiated 04/19/18.
Review of the State Registered Nursing Assistant (SRNA) [NAME] (SRNA Care Plan) dated 09/28/18, revealed Resident #15 required turning and repositioning every two (2) hours and as needed (PRN). Additionally, per the [NAME], the resident required a pressure-redistributing mattress, LAL mattress. Further review of the [NAME], revealed the resident required skin observations.
Observation on 09/25/18 at 2:27 PM; 09/25/18 at 4:21 PM; and 09/26/18 at 7:29 AM; revealed Resident #15 was lying in bed on his/her back in a semi-Fowlers position, under the covers up to his/her chest, with his/her head on a single pillow. Further, the LAL mattress settings were: Static/Alternating button was set to Alternating pressure mode; Cycle Time Button was set to ten (10) minute cycle time of inflation; Weight Setting Button (used to adjust the pressure of the inflated cells based on the patient's weight) was set to four hundred fifty (450) pounds.
Observation on 09/26/18 at 9:49 AM, revealed Resident #15 was lying in bed on his/her back in a semi-Fowlers position, under the covers up to his/her chest, with his/her head on a single pillow. SRNA #1 entered the resident's room, pulled the privacy curtain, then closed the door. At 9:54 AM, SRNA #1 exited the resident's room with a clear plastic garbage bag with a blue brief in it. However, Resident #15 remained in the same position.
Additional observation on 09/26/18 at 11:47 AM; 09/26/18 at 3:18 PM; and 09/27/18 at 8:10 AM; revealed Resident #15 was lying in bed on his/her back in a semi-Fowlers position, under the covers up to his/her chest, with his/her head on a single pillow. Further, the LAL mattress settings were Static/Alternating button was set to Alternating pressure mode; Cycle Time Button was set to ten (10) minute cycle time of inflation; Weight Setting Button (used to adjust the pressure of the inflated cells based on the patient's weight) was set to four hundred fifty (450) pounds.
Interview with the Quality Assurance (QA) Nurse/ Wound Nurse, on 09/27/18 at 9:20 AM, revealed she had worked in the facility as a Licensed Practical Nurse (LPN) for thirteen (13) years. Per interview, she was responsible for following Pressure Ulcers which were Stage II and higher. The QA Nurse stated Resident #15 was at risk for skin breakdown related to refusing to turn and reposition at times, immobility, and a history of skin breakdown. Continued interview revealed the Resident had preventative skin interventions in place including a non-sterile dressing to his/her coccyx, weekly skin assessments, a LAL mattress, and a turning and reposition program. The QA Nurse revealed, per Resident #15's turning and reposition program, the SRNAs assigned to the resident were to turn and reposition the resident every two (2) hours and as needed. Per interview, the nurses assigned to Resident #15 should be monitoring the hall during rounds for compliance and consistency to ensure the resident was turned and repositioned, as per the Care Plan.
Continued interview with the QA Nurse/ Wound Nurse, on 09/27/18 at 9:20 AM, revealed direct care floor nurses were to assess residents' skin weekly, and any skin impairment should be monitored with a description of the skin concern documented in the EMR. Per interview, this was to ensure the medical record was accurate, the resident's condition was monitored sufficiently and the resident received necessary care and services related to skin integrity. Per interview, Resident #15's reddened area to the coccyx should have been documented with a description of the area weekly from the time the area was identified.
Additional interview with the QA Nurse, revealed she was unaware of how LAL mattress settings were determined for each individual resident or how to ensure the LAL mattress was on the correct setting. She stated she thought the Physician or the company who delivered the Mattress determined the LAL mattress setting. Further interview revealed it was her expectation the CCP was followed related to skin assessments weekly, and LAL mattress. Per interview, the CCP weekly skin assessment intervention would include assessment and description of any areas of skin breakdown, and the LAL mattress intervention would include ensuring the correct setting for the individual resident, in order to provide quality care.
Observation of Resident #15, on 09/27/18 at 9:40 AM, revealed the resident was lying in bed on his/her back in semi-Fowlers position on a LAL Air Mattress. The QA Nurse initiated a skin assessment during this observation, and Resident #15 was noted to have a non-sterile adhesive dressing over his/her coccyx. Additional observation revealed when the dressing was removed from the resident's coccyx, there was an area of erythema approximately the size of a quarter, over the bony prominence of the coccyx. The QA Nurse palpated the area, which was noted to be blanchable.
Interview with SRNA #1, on 09/27/18 at 9:44 AM, revealed he checked the [NAME]/SRNA Care Plan on the kiosk in the hallways as a reference for providing care to the residents. Per interview, he reported any change in a residents' skin to the nurse. Further interview revealed Resident #15's preventative skin interventions included turning and repositioning every two (2) hours, LAL mattress, and per the nurse's direction pillows under the resident's feet. He stated he was frequently assigned to Resident #15 and the resident did not try to resist or refuse turning and repositioning. He further stated LAL mattress settings were based on the individual resident's weight; however, he had never been trained on LAL mattress setting so he never observed the settings or adjusted the settings. Continued interview revealed ensuring each resident's preventative skin interventions were in place was important to decrease a residents risk for skin breakdown, and provide good care.
Interview with SRNA #2, on 09/27/18 at 9:51 AM, revealed he reviewed the resident's [NAME]/SRNA Care Plan on the kiosk in the hallway for interventions related to providing care for residents. He stated this [NAME]/SRNA Care Plan included skin prevention interventions for each resident. The State Agency (SA) Representative and SRNA #2 reviewed Resident #15's [NAME]/SRNA Care Plan and noted interventions to turn and reposition the resident every two (2) hours, LAL mattress, and skin observation. Continued interview with SRNA #2, revealed he turned and repositioned Resident #15 every two (2) hours, without resistance or refusal. Further interview revealed he was unaware of how to determine the proper LAL mattress setting as he had never been training on monitoring or adjusting the settings.
Interview with Registered Nurse (RN) #1, on 09/27/18 at 3:18 PM, revealed all areas of skin impairment should be consistently documented on the weekly skin assessments, especially reddened areas over bony prominence which required current Physician ordered treatment. RN #1 stated accurate and consistent weekly skin assessments of all areas of skin impairment was important to evaluate if the current treatment was effective and to identify deterioration of areas of skin breakdown.
Continued interview with RN #1, revealed Resident #15 was to be turned and repositioned every two (2) hours. Per interview, she tried to ensure the resident was repositioned off his/her back, but the resident was known to wiggle onto his/her back after being turned and repositioned. However, she did state she expected the SRNAs to re-approach and re-position the resident when the resident would turn self on to his/her back. Per interview, she tried to ensure the Care Plans were followed related to turning and repositioning the residents by conducting rounds down the hallway, assisting SRNAs with resident care, and communicating with SRNAs.
Further interview with RN #1, revealed she was aware LAL mattress settings were determined by the individual resident's weight, and if the settings were not accurate the mattress may not be as effective at treating and preventing skin breakdown. However, she stated she was unaware of how to ensure the mattress setting was accurate or where the appropriate setting would be documented in the medical record. She stated the nurses initialed on the TAR every shift to indicate the LAL mattress was in place and she knew to report obvious problems with LAL mattresses, or an alarm sounding on the LAL mattress to her supervisor or the mattress company. However, she stated she was unaware of any check, or monitoring for LAL mattress settings. Continued interview with RN #1 revealed all CCP skin interventions should be followed.
Interview with the Minimum Data Set (MDS) Nurse, on 09/27/18 at 5:30 PM, revealed Resident #15 had a Care Plan intervention for weekly skin assessments and during a skin assessment the nurse was to assess and document all areas of skin impairment. Continued interview revealed accurate and consistent skin assessments were important because the assessments assisted and guided the interdisciplinary team in developing and providing necessary quality care to each resident. Per interview, the CCP was not followed related to weekly skin assessments if each area of skin impairment was not assessed. Additionally, she stated she expected preventative skin interventions to be implemented by direct care staff, including turning and repositioning residents every two (2) hours for Resident #15, as per the CCP. Further interview revealed there was an intervention on Resident #15's CCP for a LAL mattress and the company provided an initial set up including an assessment for each resident to determine the appropriate LAL mattress setting. However, per interview she was unaware of staff monitoring the LAL mattress to ensure it was effective in treating or preventing skin breakdown.
Interview with the Director of Nursing (DON), on 09/27/18 at 6:01 PM, revealed Resident #15's skin assessments should have been completed weekly to include an accurate ongoing reflection of all skin impairment, as per the CCP. Additional interview revealed turning and repositioning was expected to be provided consistently for Resident #15, as per the individualized CCP and monitored for compliance by the nurse. Continued interview revealed Resident #15 had a Care Plan intervention for a LAL mattresses, and LAL mattresses should be provided to residents at correct settings per the manufacturer's recommendation by qualified staff. However, per interview, the facility staff did not monitor or regulate the LAL mattress settings in order to ensure the mattress was an effective intervention for treatment or prevention of skin breakdown, and relied on the LAL mattress company to maintain the settings. Further interview revealed it was her expectation the CCP interventions to prevent and heal skin breakdown be followed.
Interview with the Senior Director of Clinical Services, on 09/27/18 at 5:40 PM, revealed she expected weekly skin assessments to accurately reflect the resident's skin and all skin impairment should be documented on the assessment, including reddened areas over bony prominences, as per the care plan. Additionally, she expected residents to be turned and repositioned, as per their individualized care plan. Continued interview revealed LAL mattress settings were determined by the manufacturer and were to be maintained by utilizing the Hand Check procedure. However, per interview, the individual resident's mattress settings were not documented anywhere in the facility and staff were not expected to monitor LAL mattress settings or perform the Hand Check procedure. Per interview, she did expect staff to alert the company if they noticed an obvious problem with the LAL mattress.
Interview with the Administrator, on 09/27/18 at 5:50 PM, revealed CCP interventions such as skin assessments should accurately reflect a resident's current skin status to ensure new changes in skin integrity were identified and necessary care was provided to the resident. Additional interview revealed the CCP interventions related to turning and repositioning should be implemented. Continued interview revealed staff should provide CCP interventions, such as LAL mattresses, per manufacturer's recommendations. Further interview revealed in order to provide quality care to residents, the CCP needed to be implemented.
Post Survey phone interview with the LAL mattress Representative, on 10/01/18 at 4:45 PM, revealed the distributors/providers for the LAL mattress was to provide initial set up and maintenance for LAL mattresses. Per interview, the recommendations for settings, in the User Manual, for the LAL mattresses were strictly based on weight. Further interview revealed the Physicians were to determine recommendations for the LAL mattress beyond the User Manual.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0761
(Tag F0761)
Could have caused harm · This affected 1 resident
Based on observation, interview, record review, and review of facility Policy, it was determined the facility failed to ensure proper storage of drugs and biologicals.
Observation on 09/26/18, of the ...
Read full inspector narrative →
Based on observation, interview, record review, and review of facility Policy, it was determined the facility failed to ensure proper storage of drugs and biologicals.
Observation on 09/26/18, of the South Medication Room refrigerator, revealed two (2) vials of Tubersol which were opened and not dated. Additional observation revealed a bottle of Acetylcysteine Solution which was opened, but not marked with an open date. In addition, the Acetylcysteine Solution had no pharmacy label to include the resident's name, prescription number, date, physician's name, caution statements, and directions.
Furthermore, observation 09/26/18 of the 200 Hallway medication cart, revealed an unidentified pill, which was loose and not in the packaging.
The findings include:
Review of the facility Medication Storage in the Facility Policy, undated, revealed Medications and biologicals are stored safely, securely, and properly, following the manufacturer's recommendations or those of the supplier.
Review of the facility Medication Ordering and Receiving from Pharmacy Policy, undated, revealed Medications are labeled in accordance with facility requirements, state, and federal laws. Each Prescription medication label includes, resident's name; specific directions for use, including route of administration; medication name; strength of the medication; Prescriber's name; date dispensed; quantity of medication; expiration date of medication; prescription number; accessory labels; and initials of dispensing pharmacist.
1. Review of the Mantoux Tuberculin Skin Test Facilitator Guide: Centers for Disease Control and Prevention (CDC), March 2003, revealed Tuberculin vials (Tuberculin is a sterile protein extract from cultures of tubercle bacillus, used in a test by hypodermic injection for infection with or immunity to tuberculosis) are to include the date and initials of the person opening the vial. Vials open past thirty (30) days are to be disposed of and a new vial used.
Observation on 09/26/18 at 9:00 AM, of the medication refrigerator in the south medication room, revealed two (2) vials of opened Tubersol with no date or initials on the vials. Additional Observation revealed a bottle of opened Acetylcysteine Inhalant Solution 20% (twenty percent), six (6) grams per thirty (30) milliliters (medication used to dissolve mucous in the treatment of chronic bronchitis, asthma and emphysema). There was no date to indicate the open date of the Acetylcysteine Inhalant Solution, and there was no pharmacy label to include the resident's name; dosage to be administered; prescription number; date; physician name; caution statements; and directions.
Interview with Licensed Practical Nurse (LPN) #3, on 09/26/18 at 9:10 AM, revealed multi-dose medications such as Acetylcysteine Inhalant Solution should be dated with the open date, and should have a pharmacy label to indicate the resident's name, prescription number, date issued, physician's name, caution statements, and directions. Further interview with LPN #3, revealed it was standard practice to date and initial Tubersol on the vial when opened. Per interview, Tubersol was good thirty-(30) days from the date it was opened. Continued interview revealed if Tubersol was not dated when opened, it was to be discarded because the expiration date would be unknown.
2. Observation on 09/26/18 at 9:30 AM, of the medication cart on the 200 Hallway with Certified Medication Aide (CMA) #1, revealed a single loose blue pill in a medication cup without packaging or identifying information.
Interview with CMA #1 on 09/26/18 at 4:00 PM, revealed she was not the individual who left the loose blue pill in the medication cart. Additional interview revealed prior to administering a medication, she verified the right resident, right medication, right dose, right time and right route according to the Medication Administration Record (MAR). Per interview, medications left loose and not in the packaging in the medication cart would need to be disposed of and reported to the Director of Nursing (DON).
Interview with CMA #3 on 09/26/18 at 4:24 PM, revealed if a resident did not take a medication once the package was opened, the medication should be properly discarded and the refusal should be indicated on the MAR. Additional interview revealed a loose pill left in the cart with no identifying packaging, should not be administered to a resident and the medication would need to be taken to the DON for further investigation.
Interview with Registered Nurse (RN) #1, on 09/27/18 at 10:30 AM, revealed the blue pill left in the medication cart was Proscar (medication used to treat Prostatic Hyperplasia) and the medication belonged to Resident #93. Per interview, Resident #93 did not want to take the medication (Proscar) at the time scheduled time. RN #1 stated she left the loose Proscar pill in a cup with no packaging for administration later when the resident was ready for the medication. Further interview revealed RN #1 was aware this was not proper procedure. RN #1 stated, as a standard of practice she would not administer a medication from the medication cart that was not labeled or in the package.
Interview with the DON, on 09/26/18 at 10:00 AM, revealed after her investigation the unidentified blue pill left in the medication cart on the 200 Hallway belonged to Resident #93. Per interview, the pill was identified by the facility as Proscar 5 milligrams (mg) which the resident was to receive each morning.
Further interview on 09/27/18 at 5:10 PM, with the DON, revealed it was her expectation the nurses and CMAs dispose of medication in the proper manner, if the resident refused the medication. Per interview, the nurses and CMAs were to follow the facility policies, guidelines and practices for reporting a missed dose. The DON stated she would not expect staff to administer a medication which was left in the cart opened without a package or pharmacy label as this created the potential for a medication error which could cause an adverse reaction. Additional interview revealed she would expect an unlabled medication such as the Acetylcysteine Inhalant Solution which was left in the medication refrigerator to be discarded and reported to her. Additional interview revealed Tubersol should be marked on the vial with the open date and the nurse's initials as it expired thirty (30) days after opening.
Interview with the Administrator, on 09/27/18 at 5:43 PM, revealed no nurse or CMA should leave a loose pill in the medication cart for later administration. Further interview revealed the nurses and CMAs were to follow Physician's Orders, facility policies, and the pharmacy and drug manufacturer's guidelines and recommendations when administering medications. Per interview, a multidose medication such as Tubersol should be marked with the open date as the medication expired thirty (30) days after opening. The Administrator stated all multidose medications were to be labeled according to the facilities policies and standards of practice.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Medical Records
(Tag F0842)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, record review, and review if the facility's Policy, it was determined the facility failed to ma...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, record review, and review if the facility's Policy, it was determined the facility failed to maintain medical records in accordance with accepted professional standards and practices that are complete and accurately documented for one (1) of twenty-two (22) sampled residents (Resident #41).
Resident #41 had an order for a suprapubic catheter prior to being transferred and admitted to the hospital on [DATE]. The resident was re-admitted to the facility on [DATE] with a suprapubic catheter; however, there was no documented evidence the new re-admission orders or current active Physician's Orders included orders for the suprapubic catheter.
The findings include:
Review of the facility's Physician Medication Orders Policy, dated 08/01/13, revealed the Charge Nurse or the Director of Nursing Services shall forward to pharmacy the order for all prescribed medications. Drug and biological orders must be recorded on the Physician's Order Sheet in the resident's chart. Continued review of the Policy, revealed orders must be recorded immediately in the resident's chart by the person receiving the order and must include the date and time order.
Review of Resident #41's medical record revealed the facility admitted the resident on 12/16/15, with diagnoses of Congestive Heart Failure, Peripheral Vascular Disease, and Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms.
Further review of Resident #41's medical record revealed the facility transferred Resident #41 to the hospital on 7/11/18 related to a Urinary Tract Infection and the resident was admitted to the hospital on that date. The facility re-admitted Resident #41 on 07/14/18.
Review of Resident #41's current Physician Orders dated 09/06/18, with the original date of 07/14/18, revealed an order to cleanse supra pubic cath site with wound cleanser and apply drainage sponge (every day shift); however, there review of the re-admission orders dated 07/14/18 and the current active Physician's Order related there was no orders for a suprapubic catheter.
Observation of Resident #41, on 09/26/18 at 9:30 AM, revealed the resident had a suprapubic catheter in place with drainage bag draining on the right side of the bed.
Interview with Licensed Practical Nurse (LPN) #1, on 9/27/18 at 4:05 PM, revealed when a facility transferred or discharged a resident to the hospital, and the resident was admitted to the hospital, the nurse placed the resident's Physician's Orders on hold. Per interview, when and if the resident was re-admitted to the facility, the orders on hold were then to be restarted per the doctor's approval and two (2) nurses were to verify the orders were correct. Further interview revealed if a resident had a suprapubic catheter in place, there should be an active order for the catheter.
Interview with LPN #2, on 9/27/17 at 5:01 PM, revealed when the facility transferred or discharged a resident to the hospital, and the resident was admitted to the hospital, the nurse obtained a bed hold and placed the resident's current orders on hold. Per interview, when the resident was re-admitted to the facility, the orders were to be re-activated. LPN #2 stated previous orders which were on hold and any new orders were to be checked and verified by two (2) nurses per the doctor's approval. Further interview revealed if a resident had a suprapubic catheter in place on re-admission to the facility, there should be an active Physician's Order for the catheter and an order for catheter care.
Interview with the Director of Nursing (DON), Senior Clinical Service Director (SCSD) and the Administrator on 09/27/18 at 5:30 PM, revealed Resident #41 should have had an active order for a suprapubic catheter upon re-admission to the facility in order for there to be an , accurate representation of the resident. The SCSD stated the lack of an order for Resident #41's suprapubic catheter was most likely a result due to a transcription error during re-admission.